IP Library Granted Patent US 12,487,152
Granted Patent B2
US 12,487,152 · App. 16/612,002 · Granted Dec 2, 2025

Scalable method for producing transfection reagents

Inventors: Jan Panteli (Cambridge, MA); Ying Jing (Reinach, CH)
Assignee: Ultragenyx Pharmaceutical Inc.
G01N1/28C12M23/14C12M23/26C12M23/28C12M27/16C12N7/00C12N15/85C12N2750/14111
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,487,152
App. No.
16/612,002
Granted
Dec 2, 2025
Kind
B2
Abstract

The invention provides easy-to-scale methods of creating DNA/transfection reagent master mixes for transfecting cells in culture.

Claims (20)

1 . A method of preparing a transfection master mix comprising the steps of:

(1) introducing a DNA solution and a transfection reagent solution into a mixing container to create a transfection master mix, wherein the volume of the transfection master mix is 1 L or greater;

(2) rocking the mixing container with a mechanical rocking device for a period of about 1 minute to about 10 minutes at 10 rpm to 15 rpm and about 7 degrees to about 12 degrees rocking angle to reach a steady state concentration of DNA within the transfection master mix; and

(3) incubating the transfection master mix for an incubation period of about 20 minutes to about 30 minutes, wherein the transfection master mix is substantially still during the incubation period;

wherein the transfection master mix consists essentially of the DNA solution and the transfection reagent solution;

wherein the DNA solution comprises plasmids selected from the group consisting of recombinant adeno-associated virus (rAAV) cis plasmids, rAAV trans-rep-cap plasmids, and helper plasmids; and

wherein the transfection master mix is for co-transfection of rAAV packaging cells for rAAV production.

2 . The method of claim 1 , wherein the mixing container is (a) a single-use disposable container; (b) a pre-sterilized container; (c) a plastic bag; or (d) a single-use cell culture bag.

3 . The method of claim 2 , wherein the mixing container is a plastic bag or a single-use cell culture bag, which bag is fully or partially inflated.

4 . The method of claim 1 , wherein the transfection reagent solution comprises a chemical transfection reagent selected from the group consisting of: a cationic polymer, calcium phosphate, DEAE-dextran, an activated dendrimer, and a cationic lipid.

5 . The method of claim 4 , wherein the cationic polymer is polyethylenimine.

6 . The method of claim 1 , wherein the DNA solution and/or the transfection reagent solution is sterile.

7 . The method of claim 1 further comprising the step of (a) sterilizing the DNA solution prior to introducing the DNA solution into the mixing container;

and/or (b) sterilizing the transfection reagent solution prior to introducing the transfection reagent solution into the mixing container.

8 . The method of claim 1 , wherein the mechanical rocking device comprises a rocking platform.

9 . The method of claim 1 , wherein the volume of the transfection master mix is 3 L or greater, 12 L or greater, 15 L or greater, 25 L or greater, 50 L or greater, or 100 L or greater.

10 . The method of claim 1 , wherein the volume of the transfection master mix is between 1 L and 100 L.

11 . The method of claim 10 , wherein the volume of the transfection master mix is 1 L, 3 L, 12 L, 15 L, 25 L, or 29 L.

12 . The method of claim 1 , wherein (a) the volume of the transfection master mix is 4 L, and the rocking the mixing container is at an angle of 7 degrees, at 10 rpm, and for about 1 minute to about 2 minutes; or (b) the volume of the transfection master mix is 12 L, and the rocking the mixing container is at an angle of 12 degrees, at 15 rpm, and for about 1 minute to about 2 minutes.

13 . The method of claim 1 , wherein the step of introducing the DNA solution and the transfection reagent solution into the mixing container is accomplished sterilely.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2022
From: PANTELI, JAN; JING, YING
To: DIMENSION THERAPEUTICS, INC.
Reel/Frame 059046/0833 →
MERGER AND CHANGE OF NAME Recorded Feb 18, 2022
From: DIMENSION THERAPEUTICS, INC.; ULTRAGENYX PHARMACEUTICAL INC.
To: ULTRAGENYX PHARMACEUTICAL INC.
Reel/Frame 059046/0858 →
Continuity (2)
Provisional Application 62503660 · May 9, 2017
Related Publication 20200124505A1 · Apr 23, 2020
References Cited (52)
US 5387484A · Doany et al. · 1995 [cited by applicant]
US 5658785A · Johnson · 1997 [cited by applicant]
US 5688676A · Zhou et al. · 1997 [cited by applicant]
US 5691176A · Lebkowski et al. · 1997 [cited by applicant]
US 5741683A · Zhou et al. · 1998 [cited by applicant]
US 5872005A · Wang et al. · 1999 [cited by applicant]
US 6004797A · Colosi · 1999 [cited by applicant]
US 6127175A · Vigne et al. · 2000 [cited by applicant]
US 6156303A · Russell et al. · 2000 [cited by applicant]
US 6489162B1 · Shenk et al. · 2002 [cited by applicant]
US 6566118B1 · Atkinson et al. · 2003 [cited by applicant]
US 6723551B2 · Kotin et al. · 2004 [cited by applicant]
US 6753419B1 · Toniatti et al. · 2004 [cited by applicant]
US 6846665B1 · Horer et al. · 2005 [cited by applicant]
US 6943019B2 · Wilson et al. · 2005 [cited by applicant]
US 7271002B2 · Kotin et al. · 2007 [cited by applicant]
US 7510872B2 · Clark et al. · 2009 [cited by applicant]
US 8076139B1 · Hamm · 2011 [cited by examiner]
US 8163543B2 · Urabe et al. · 2012 [cited by applicant]
US 8409842B2 · Clark et al. · 2013 [cited by applicant]
US 8512981B2 · Hermens et al. · 2013 [cited by applicant]
US 8980247B2 · Meyers et al. · 2015 [cited by applicant]
US 20020081721A1 · Allen et al. · 2002 [cited by applicant]
US 20020115189A1 · Natsoulis et al. · 2002 [cited by applicant]
US 20020127582A1 · Atkinson et al. · 2002 [cited by applicant]
US 20040053410A1 · Horer et al. · 2004 [cited by applicant]
US 20040235173A1 · Bleck et al. · 2004 [cited by applicant]
US 20050112765A1 · Li et al. · 2005 [cited by applicant]
US 20050148076A1 · Allen · 2005 [cited by applicant]
US 20060013063A1 · Singh · 2006 [cited by applicant]
US 20100248355A1 · Atkinson et al. · 2010 [cited by applicant]
US 20110251547A1 · Xing et al. · 2011 [cited by applicant]
US 20120058917A1 · Gaken et al. · 2012 [cited by applicant]
US 20130035371A1 · Fitzgerald et al. · 2013 [cited by applicant]
US 20140056919A1 · Xing et al. · 2014 [cited by applicant]
US 20140359799A1 · Wang et al. · 2014 [cited by applicant]
US 20150024467A1 · Sheldon et al. · 2015 [cited by applicant]
US 20150353899A1 · Pechan et al. · 2015 [cited by applicant]
US 20160257972A1 · van der Loo et al. · 2016 [cited by applicant]
ES 2266197T3 · 2007 [cited by applicant]
ES 2358315T3 · 2011 [cited by applicant]
WO WO1999063064A1 · 1999 [cited by applicant]
WO WO2013063379A1 · 2013 [cited by applicant]
WO WO2014018423A2 · 2014 [cited by applicant]
Qiagen “Effectene Transfection Reagent Handbook” May 2002 (Year: 2002). [cited by examiner]
Raymond et al. A simplified poyethylenimine-mediated transfection process for large-scale and high-throughput applications (Year: 2011). [cited by examiner]
Extended European Search Report for corresponding European Application No. 18798067.7 dated Nov. 30, 2020. [cited by applicant]
O'Hagan et al., “Microparticle-based technologies for vaccines”, Methods. vol. 40, No. 1 (2006), pp. 10-19. [cited by applicant]
Grieger et al., “Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector”, American Society of … [cited by applicant]
International Search Report and Written Opinion for corresponding International Application No. PCT/US2018/031865 dated Jul. 20, 2018. [cited by applicant]
Qiagen, “Effectene transfection reagent handbook”, (2002), pp. 1-28. [cited by applicant]
Raymond et al., “A simplified polyethylenimine-mediated transfection process for large-scale and high-throughput applications”, Methods. (2011), pp. 1-8. [cited by applicant]